Table 1 Clinical features of the current patient and a previously reported patient with RAC1 variants adjacent to the Switch I region.

From: A missense variant at the RAC1-PAK1 binding site of RAC1 inactivates downstream signaling in VACTERL association

 

Our case

Individual 2a

Clinical information

 Gender

Male

Male

 Race

Japanese

European

 Age at examination

30 weeks and 3 days of gestation

9 years

 Height

40 cm (0.10 SD)

128 cm (− 2.5 SD)

 Weight

1406 g (− 0.69 SD)

24 kg (− 0.5 SD)

Mutation (GenBank: NM_018890.4)

 Chromosome position (GRCh37/hg19)

chr7:6431565

chr7:6431563

 gDNA change

c.118T > C

c.116A > G

 Amino acid change

p.(Tyr40His)

p.(Asn39Ser)

 SIFT

0

0

 PolyPhen-2

0.731

0.999

 CADD

26.7

24.2

 MutationTaster

Disease-causing

Disease-causing

 ACMG/AMP Guidelines (Criteria)

Likely pathogenic (PS2, PM1, PM2, PP3)

Pathogenic (PS3, PM1, PM2, PM6, PP3, PP4)

Developmental and neurological findings

 Intellectual disability (degree)

NA

Yes (mild-moderate)

 Epilepsy

NA

No

 Hypotonia

NA

No

Brain MRI abnormalities

 

Not performed

Cerebellar abnormalities, Hypoplasia corpus callosum, Enlarged lateral ventricles, Enlarged fourth ventricle, Thin pons, Mega cisterna magna

Craniofacial dysmorphisms

 Low set ears

Yes

Yes

 Micrognathism

Yes

Yes

 Arched eyebrows

Yes

Yes

 Prominent nasal bridge

No

No

Congenital abnormalities

 Cardiac abnormalities

PLSVC, TAPVR

No

 Tracheoesophageal malformation

Esophagobronchial fistula

No

 Skeletal abnormalities

Scoliosis, 10th thoracic vertebra hypoplasia; synostosis of 6th and 7th costa, tracheal aplasia

No

 Hand deformities

Polydactyly 1st digit on right-hand

No

Other

 Neonatal feeding difficulties

Yes

Yes

 Other

Died on the first day after delivery

Polyhydramnios

Recurrent pneumonia

Eczema

  1. NA not available, PLSVC persistent left superior vena cava, SD standard deviation, TAPVR: total anomalous pulmonary venous return. The pathogenicity of each prediction score was judged according to the following values: SIFT < 0.05 (Deleterious), PolyPhen-2 0.65–1.0 (Damaging), and CADD (phred score) ≥ 20 (Pathogenic). aReijnders et al.13.